1 - 6 toradh á dtaispeáint as 6 toradh san iomlán ar an gcuardach 'Flynt, E', am iarratais: 0.02s Beachtaigh na torthaí
  1. 1
    Reading iventory : for the classroom /

    Reading iventory : for the classroom / de réir 449570 Flynt, E. Sutton, Cooter, Robert B.

    Foilsithe / Cruthaithe 1998
  2. 2
    Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma

    Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma de réir Amatangelo, M, Flynt, E, Stong, N, Ray, P, Van Oekelen, O, Wang, M, Ortiz, M, Maciag, P, Peluso, T, Parekh, S, van de Donk, NWCJ, Lonial, S, Thakurta, A

    Foilsithe / Cruthaithe 2024
    Journal article
  3. 3
    Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients

    Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients de réir Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Salazar, MA, Fitzsimons, E, Estevez, MO, Towfic, F, Flynt, E, Pierceall, WE, Yong, K, Vyas, P, Thakurta, A

    Foilsithe / Cruthaithe 2021
    Conference item
  4. 4
    Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

    Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma de réir Gooding, S, Ansari-Pour, N, Towfic, F, Ortiz Estévez, M, Chamberlain, PP, Tsai, K-T, Flynt, E, Hirst, M, Rozelle, D, Dhiman, P, Neri, P, Ramasamy, K, Bahlis, N, Vyas, P, Thakurta, A

    Foilsithe / Cruthaithe 2020
    Journal article
  5. 5
    Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma

    Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma de réir Van Oekelen, O, Amatangelo, M, Guo, M, Upadhyaya, B, Cribbs, AP, Kelly, G, Patel, M, Kim-Schulze, S, Flynt, E, Lagana, A, Gooding, S, Merad, M, Jagganath, S, Pierceall, WE, Oppermann, U, Thakurta, A, Parekh, S

    Foilsithe / Cruthaithe 2024
    Journal article
  6. 6
    Loss Of COP9-signalosome genes Aa 2q37 is associated with IMiD agent resistance in multiple myeloma

    Loss Of COP9-signalosome genes Aa 2q37 is associated with IMiD agent resistance in multiple myeloma de réir Gooding, S, Ansari-Pour, N, Kazeroun, MH, Karagoz, K, Polonskaia, A, Angulo Salazar, M, Fitzsimons, E, Sirinukunwattana, K, Chavda, SJ, Ortiz Estevez, M, Towfic, F, Flynt, E, Pierceall, W, Royston, D, Yong, KL, Ramasamy, K, Vyas, P, Thakurta, A

    Foilsithe / Cruthaithe 2022
    Journal article

Uirlisí cuardaigh: